Table 4.
Logistic regression analysis for risk factors attributing to in-hospital mortality in the study.
| Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|
| Variable | OR (95% CI) | P-value | OR (95% CI) | P-value |
| Age, years | 1.019 (0.994–1.045) | 0.132 | ||
| Gender, male | 0.633 (0.314–1.276) | 0.201 | ||
| History of HBP | 2.362 (1.228–4.547) | 0.01 | ||
| History of DM | 1.658 (0.736–3.735) | 0.222 | ||
| Killip grade II–IV | 3.161 (1.660–6.019) | <0.001* | 1.446 (0.647–3.232) | 0.369 |
| Peak value of CK-MB | 1.000 (0.999–1.001) | 0.938 | ||
| With left main or tripple vessels lesions | 0.520 (0.251–1.079) | 0.079 | ||
| Left ejection fraction | 0.007 (0.001–1.067) | <0.001* | 0.031 (0.002–0.533) | 0.017* |
| Left atrium diameter | 0.989 (0.948–1.031) | 0.594 | ||
| Complicated with FHG | 11.130 (4.130–28.741) | <0.001* | 8.134 (2.664–24.841) | <0.001* |
| With new onset AF | 6.580 (3.400–12.736) | <0.001* | 6.612 (2.878–15.191) | <0.001* |
| PCI performed | 0.348 (0.184–0.658) | 0.001* | 0.583 (0.257–1.322) | 0.196 |
| Use of ACEI/ARB | 0.097 (0.045–0.208) | <0.001* | 0.342 (0.114–1.024) | 0.055 |
| Use of β-blocker | 0.213 (0.108–0.420) | <0.001 | 0.226 (0.081–0.628) | 0.044* |
| Use of diuretics | 0.890 (0.502–1.581) | 0.692 |
DM, diabetic mellitus; HBP, hypertensive blood pressure; CK-MB, creatine kinase-MB isoenzyme; FHG, fasting hyperglycemia; AF, atrial fibrillation; PCI, Percutaneous coronary intervention; ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker;
*
P < 0.05.